Financial Reports

Interim report Q3 2025 (in Swedish)
Interim report Q2 2025 (in Swedish)
Interim report Q1 2025 (in Swedish)
Annual General Meeting 2025:
Notice of annual general meeting (in Swedish)
Power of Attorney (in Swedish)
Bulletin from the annual general meeting
Annual report 2024 (in Swedish)
Interim report Q4 2024 (in Sw edish)
Interim report Q3 2024 (in Swedish)
Interim report Q2 2024 (in Swedish)
Interim report Q1 2024 (in Swedish)
Extraordinary general meeting 2024
Notice of extraordinary general meeting
Power of Attorney
Annual General Meeting 2024:
Notice of annual general meeting
Proposal for resolution on authorization regarding issues
Power of Attorney
Bulletin from the Annual General Meeting (in Swedish)
Annual report 2023 (in Swedish)
Interim report Q4 2023 (in Swedish)
Interim report Q3 2023 (in Swedish)
Interim report Q2 2023
Interim report Q1 2023
Annual General Meeting 2023:
Notice of annual general meeting
Proposal for resolution on authorization regarding issues
Power of Attorney template
Minutes from AGM
Annual report 2022
Memorandum
Annual report 2022
Interim report Q4 2022 (in Swedish)

Financial reports prior to Q4 2022 are available here.

Financial Calendar

Year-End Report 2025 – 26 February 2026

Annual Report – 6 May 2026

Annual General Meeting (AGM) – 27 May 2026

Interim Report Q1 – 27 May 2026

Interim Report Q2 – 27 August 2026

Interim Report Q3 – 19 November 2026

Year-End Report 2026 – 25 February 2027

(already communicated in the Q3 report)

CHOSA Oncology

Ole Maaløes Vej 3, 2200 København (Denmark)
c/o ECIT Services, AB Kungsgatan 6, 211 49 Malmö (Sweden)
Org.no: 559037-2271

Contact us

info@chosa.bio
+45 21 60 89 22